Alveolar macrophages: Plasticity in a tissue-specific context

Nature Reviews Immunology

Volumn 14, Issue 2, 2014, Pages 81-93

  Hussell, Tracy ^a   Bell, Thomas J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD200 RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; MACROPHAGE RECEPTOR WITH COLLAGENOUS STRUCTURE; MANNOSE RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN; SIGNAL REGULATORY PROTEIN ALPHA; SURFACTANT ASSOCIATED PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; APOPTOSIS; BRONCHUS MUCOSA; CHRONIC OBSTRUCTIVE LUNG DISEASE; EPITHELIUM CELL; EX VIVO STUDY; HAEMOPHILUS INFLUENZAE; HUMAN; HYPOXIA; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; LUNG STRUCTURE; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PLASTICITY; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RESPIRATORY TRACT DISEASE; REVIEW; RHINOVIRUS INFECTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TISSUE SPECIFICITY; UPREGULATION;

ANIMALS; ANTIGENS, SURFACE; CELLULAR MICROENVIRONMENT; HUMANS; LECTINS, C-TYPE; MACROPHAGE ACTIVATION; MACROPHAGES, ALVEOLAR; MANNOSE-BINDING LECTINS; MEMBRANE GLYCOPROTEINS; ORGAN SPECIFICITY; PPAR GAMMA; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 84893652705     PISSN: 14741733     EISSN: 14741741     Source Type: Journal    
DOI: 10.1038/nri3600     Document Type: Review

References (162)

1. Gordon, S. and Taylor, P. R. Monocyte and macrophage heterogeneity. Nature Rev. Immunol. 5, 953-964 (2005).
2. Geissmann, F. et al. Development of monocytes, macrophages, and dendritic cells. Science 327, 656-661 (2010).
3. Schulz, C. et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336, 86-90 (2012).
4. Guilliams, M. et al. Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF. J. Exp. Med. 210, 1977-1992 (2013).
5. Schmidt, A. et al. Macrophages in experimental rat lung isografts and allografts: infiltration and proliferation in situ. J. Leukoc. Biol. 81, 186-194 (2007).
6. Tarling, J. D., Lin, H. S. and Hsu, S. Self-renewal of pulmonary alveolar macrophages: evidence from radiation chimera studies. J. Leukoc. Biol. 42, 443-446 (1987).
7. Sawyer, R. T., Strausbauch, P. H. and Volkman, A. Resident macrophage proliferation in mice depleted of blood monocytes by strontium-89. Lab Invest. 46, 165-170 (1982).
8. Hashimoto, D. et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity 38, 792-804 (2013).
9. Yona, S. et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 38, 79-91 (2013).
10. Ghoneim, H. E., Thomas, P. G. and McCullers, J. A. Depletion of alveolar macrophages during influenza infection facilitates bacterial superinfections. J. Immunol. 191, 1250-1259 (2013).
11. Worlitzsch, D. et al. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 109, 317-325 (2002).
12. Schaible, B., Schaffer, K. and Taylor, C. T. Hypoxia, innate immunity and infection in the lung. Respir. Physiol. Neurobiol. 174, 235-243 (2010).
13. Cummins, E. P. et al. Prolyl hydroxylase-1 negatively regulates IκB kinase-β, giving insight into hypoxia-induced NFκB activity. Proc. Natl Acad. Sci. USA 103, 18154-18159 (2006).
14. Leonard, M. O. et al. Hypoxia selectively activates the CREB family of transcription factors in the in vivo lung. Am. J. Respir. Crit. Care Med. 178, 977-983 (2008).
15. Goulding, J. et al. Lowering the threshold of lung innate immune cell activation alters susceptibility to secondary bacterial superinfection. J. Infect. Dis. 204, 1086-1094 (2011).
16. Charlson, E. S. et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am. J. Respir. Crit. Care Med. 184, 957-963 (2011).
17. Snelgrove, R. J. et al. A critical function for CD200 in lung immune homeostasis and the severity of influenza infection. Nature Immunol. 9, 1074-1083 (2008).
18. Munger, J. S. et al. The integrin αvβ6 binds and activates latent TGFβ1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 96, 319-328 (1999).
19. Bonfield, T. L. et al. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am. J. Respir. Cell. Mol. Biol. 13, 257-261 (1995).
20. Ely, K. H., Cookenham, T., Roberts, A. D. and Woodland, D. L. Memory T cell populations in the lung airways are maintained by continual recruitment. J. Immunol. 176, 537-543 (2006).
21. Snelgrove, R. J., Godlee, A. and Hussell, T. Airway immune homeostasis and implications for influenza-induced inflammation. Trends Immunol. 32, 328-334 (2011).
22. Lipscomb, M. F. et al. Human alveolar macrophages: HLA-DR-positive macrophages that are poor stimulators of a primary mixed leukocyte reaction. J. Immunol. 136, 497-504 (1986).
23. Lyons, C. R. et al. Inability of human alveolar macrophages to stimulate resting T cells correlates with decreased antigen-specific T cell-macrophage binding. J. Immunol. 137, 1173-1180 (1986).
24. Toews, G. B. et al. The accessory cell function of human alveolar macrophages in specific T cell proliferation. J. Immunol. 132, 181-186 (1984).
25. Kirby, A. C., Coles, M. C. and Kaye, P. M. Alveolar macrophages transport pathogens to lung draining lymph nodes. J. Immunol. 183, 1983-1989 (2009).
26. Blumenthal, R. L. et al. Human alveolar macrophages induce functional inactivation in antigen-specific CD4 T cells. J. Allergy Clin. Immunol. 107, 258-264 (2001).
27. Holt, P. G. Inhibitory activity of unstimulated alveolar macrophages on T-lymphocyte blastogenic response. Am. Rev. Respir. Dis. 118, 791-793 (1978).
28. Hoidal, J. R., Schmeling, D. and Peterson, P. K. Phagocytosis, bacterial killing, and metabolism by purified human lung phagocytes. J. Infect. Dis. 144, 61-71 (1981).
29. Roth, M. D. and Golub, S. H. Human pulmonary macrophages utilize prostaglandins and transforming growth factor-β1 to suppress lymphocyte activation. J. Leukoc. Biol. 53, 366-371 (1993).
30. Coleman, M. M. et al. Alveolar macrophages contribute to respiratory tolerance by inducing FoxP3 expression in naive T cells. Am. J. Respir. Cell. Mol. Biol. 48, 773-780 (2013).
31. Soroosh, P. et al. Lung-resident tissue macrophages generate Foxp3+ regulatory T cells and promote airway tolerance. J. Exp. Med. 210, 775-788 (2013).
32. Kaur, M. et al. T lymphocyte insensitivity to corticosteroids in chronic obstructive pulmonary disease. Respir. Res. 13, 20 (2012).
33. Maus, U. A. et al. Resident alveolar macrophages are replaced by recruited monocytes in response to endotoxin-induced lung inflammation. Am. J. Respir. Cell. Mol. Biol. 35, 227-235 (2006).
34. Janssen, W. J. et al. Fas determines differential fates of resident and recruited macrophages during resolution of acute lung injury. Am. J. Respir. Crit. Care Med. 184, 547-560 (2011).
35. Hoppstadter, J. et al. Differential cell reaction upon Toll-like receptor 4 and 9 activation in human alveolar and lung interstitial macrophages. Respir. Res. 11, 124 (2010).
36. Gordon, S. Alternative activation of macrophages. Nature Rev. Immunol. 3, 23-35 (2003).
37. Martinez, F. O., Sica, A., Mantovani, A. and Locati, M. Macrophage activation and polarization. Front. Biosci. 13, 453-461 (2008).
38. Edwards, J. P., Zhang, X., Frauwirth, K. A. and Mosser, D. M. Biochemical and functional characterization of three activated macrophage populations. J. Leukoc. Biol. 80, 1298-1307 (2006).
39. Mosser, D. M. and Edwards, J. P. Exploring the full spectrum of macrophage activation. Nature Rev. Immunol. 8, 958-969 (2008).
40. Shaykhiev, R. et al. Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease. J. Immunol. 183, 2867-2883 (2009).
41. Kim, E. Y. et al. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nature Med. 14, 633-640 (2008).
42. Melgert, B. N. et al. More alternative activation of macrophages in lungs of asthmatic patients. J. Allergy Clin. Immunol. 127, 831-833 (2011).
43. Pechkovsky, D. V. et al. Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction. Clin. Immunol. 137, 89-101 (2010).
44. Draijer, C., Robbe, P., Boorsma, C. E., Hylkema, M. N. and Melgert, B. N. Characterization of macrophage phenotypes in three murine models of house-dust-mite-induced asthma. Mediators Inflamm. 2013, 632049 (2013).
45. Zaynagetdinov, R. et al. Identification of myeloid cell subsets in murine lungs using flow cytometry. Am. J. Respir. Cell. Mol. Biol. 49, 180-189 (2013).
46. Malhotra, V., Hogg, N. and Sim, R. B. Ligand binding by the p150,95 antigen of U937 monocytic cells: properties in common with complement receptor type 3 (CR3). Eur. J. Immunol. 16, 1117-1123 (1986).
47. Guth, A. M. et al. Lung environment determines unique phenotype of alveolar macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 296, L936-L946 (2009).
48. Inaba, K. et al. Tissue distribution of the DEC-205 protein that is detected by the monoclonal antibody NLDC-145. I. Expression on dendritic cells and other subsets of mouse leukocytes. Cell. Immunol. 163, 148-156 (1995).
49. Lahoud, M. H. et al. DEC-205 is a cell surface receptor for CpG oligonucleotides. Proc. Natl Acad. Sci. USA 109, 16270-16275 (2012).
50. Misharin, A. V., Morales-Nebreda, L., Mutlu, G. M., Budinger, G. R. and Perlman, H. Flow cytometric analysis of the macrophages and dendritic cell subsets in the mouse lung. Am. J. Respir. Cell Mol. Biol. 49, 503-510 (2013).
51. Zhang, M. et al. Defining the in vivo function of Siglec-F, a CD33-related Siglec expressed on mouse eosinophils. Blood 109, 4280-4287 (2007).
52. Mao, H. et al. Mechanisms of Siglec-F-induced eosinophil apoptosis: a role for caspases but not for SHP-1 Src kinases, NADPH oxidase or reactive oxygen. PLoS ONE. 8, e68143 (2013).
53. Song, D. J. et al. Anti-Siglec-F antibody reduces allergen-induced eosinophilic inflammation and airway remodeling. J. Immunol. 183, 5333-5341 (2009).
54. Mayer, A. K., Bartz, H., Fey, F., Schmidt, L. M. and Dalpke, A. H. Airway epithelial cells modify immune responses by inducing an anti-inflammatory microenvironment. Eur. J. Immunol. 38, 1689-1699 (2008).
55. Wright, G. J. et al. Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. Immunity 13, 233-242 (2000).
56. Koning, N. et al. Expression of the inhibitory CD200 receptor is associated with alternative macrophage activation. J. Innate Immun. 2, 195-200 (2010).
57. Hatherley, D. and Barclay, A. N. The CD200 and CD200 receptor cell surface proteins interact through their N-terminal immunoglobulin-like domains. Eur. J. Immunol. 34, 1688-1694 (2004).
58. Jiang-Shieh, Y. F. et al. Distribution and expression of CD200 in the rat respiratory system under normal and endotoxin-induced pathological conditions. J. Anat. 216, 407-416 (2010).
59. Zhang, S., Cherwinski, H., Sedgwick, J. D. and Phillips, J. H. Molecular mechanisms of CD200 inhibition of mast cell activation. J. Immunol. 173, 6786-6793 (2004).
60. Mihrshahi, R., Barclay, A. N. and Brown, M. H. Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells. J. Immunol. 183, 4879-4886 (2009).
61. Mihrshahi, R. and Brown, M. H. Downstream of tyrosine kinase 1 and 2 play opposing roles in CD200 receptor signaling. J. Immunol. 185, 7216-7222 (2010).
62. Barclay, A. N. Signal regulatory protein-α (SIRPα)/ CD47 interaction and function. Curr. Opin. Immunol. 21, 47-52 (2009).
63. Shultz, L. D., Rajan, T. V. and Greiner, D. L. Severe defects in immunity and hematopoiesis caused by SHP-1 protein-tyrosine-phosphatase deficiency. Trends Biotechnol. 15, 302-307 (1997).
64. Gardai, S. J. et al. By binding SIRPα or calreticulin/ CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 115, 13-23 (2003).
65. Burger, P., Hilarius-Stokman, P., deKorte, D. and van den Berg, T. K. and van Bruggen, R. CD47 functions as a molecular switch for erythrocyte phagocytosis. Blood 119, 5512-5521 (2012).
66. Oldenborg, P. A. et al. Role of CD47 as a marker of self on red blood cells. Science 288, 2051-2054 (2000).
67. Legrand, N. et al. Functional CD47/signal regulatory protein alpha (SIRPα) interaction is required for optimal human T and natural killer- (NK) cell homeostasis in vivo. Proc. Natl Acad. Sci. USA 108, 13224-13229 (2011).
68. Wang, H. et al. Lack of CD47 on nonhematopoietic cells induces split macrophage tolerance to CD47null cells. Proc. Natl Acad. Sci. USA 104, 13744-13749 (2007).
69. van Beek, E. M., Cochrane, F., Barclay, A. N. and van den Berg, T. K. Signal regulatory proteins in the immune system. J. Immunol. 175, 7781-7787 (2005).
70. Barclay, A. N. and Brown, M. H. The SIRP family of receptors and immune regulation. Nature Rev. Immunol. 6, 457-464 (2006).
71. Gardai, S. J. et al. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 123, 321-334 (2005).
72. Oldenborg, P. A. Role of CD47 in erythroid cells and in autoimmunity. Leuk. Lymphoma 45, 1319-1327 (2004).
73. Janssen, W. J. et al. Surfactant proteins A and D suppress alveolar macrophage phagocytosis via interaction with SIRPα. Am. J. Respir. Crit. Care Med. 178, 158-167 (2008).
74. Steele, C. et al. Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 β-glucan receptor. J. Exp. Med. 198, 1677-1688 (2003).
75. Neese, L. W., Standing, J. E., Olson, E. J., Castro, M. and Limper, A. H. Vitronectin, fibronectin, and gp120 antibody enhance macrophage release of TNFα in response to Pneumocystis carinii. J. Immunol. 152, 4549-4556 (1994).
76. Zhang, J. et al. Negative regulatory role of mannose receptors on human alveolar macrophage proinflammatory cytokine release in vitro. J. Leukoc. Biol. 78, 665-674 (2005).
77. Ghosh, S., Gregory, D., Smith, A. and Kobzik, L. MARCO regulates early inflammatory responses against influenza: a useful macrophage function with adverse outcome. Am. J. Respir. Cell. Mol. Biol. 45, 1036-1044 (2011).
78. Gao, X., Dong, Y., Liu, Z. and Niu, B. Silencing of triggering receptor expressed on myeloid cells-2 enhances the inflammatory responses of alveolar macrophages to lipopolysaccharide. Mol. Med. Rep. 7, 921-926 (2013).
79. Colonna, M. TREMs in the immune system and beyond. Nature Rev. Immunol. 3, 445-453 (2003).
80. Habibzay, M., Saldana, J. I., Goulding, J., Lloyd, C. M. and Hussell, T. Altered regulation of Toll-like receptor responses impairs antibacterial immunity in the allergic lung. Mucosal. Immunol. 5, 524-534 (2012).
81. Khoor, A., Gray, M. E., Hull, W. M., Whitsett, J. A. and Stahlman, M. T. Developmental expression of SP-A and SP-A mRNA in the proximal and distal respiratory epithelium in the human fetus and newborn. J. Histochem. Cytochem. 41, 1311-1319 (1993).
82. Watford, W. T., Wright, J. R., Hester, C. G., Jiang, H. and Frank, M. M. Surfactant protein A regulates complement activation. J. Immunol. 167, 6593-6600 (2001).
83. Yamada, C. et al. Surfactant protein A directly interacts with TLR4 and MD-2 and regulates inflammatory cellular response. Importance of supratrimeric oligomerization. J. Biol. Chem. 281, 21771-21780 (2006).
84. Sano, H. et al. Pulmonary surfactant protein A modulates the cellular response to smooth and rough lipopolysaccharides by interaction with CD14. J. Immunol. 163, 387-395 (1999).
85. Haczku, A. Protective role of the lung collectins surfactant protein A and surfactant protein D in airway inflammation. J. Allergy Clin. Immunol. 122, 861-879 (2008).
86. Morris, D. G. et al. Loss of integrin αvβ6-mediated TGFβ activation causes Mmp12-dependent emphysema. Nature 422, 169-173 (2003).
87. Markowitz, S. et al. Inactivation of the type II TGFβ receptor in colon cancer cells with microsatellite instability. Science 268, 1336-1338 (1995).
88. Derynck, R. and Zhang, Y. E. Smad-dependent and Smad-independent pathways in TGFβ family signalling. Nature 425, 577-584 (2003).
89. Rojas, A., Padidam, M., Cress, D. and Grady, W. M. TGFβ receptor levels regulate the specificity of signaling pathway activation and biological effects of TGFβ. Biochim. Biophys. Acta 1793, 1165-1173 (2009).
90. Coker, R. K. et al. Diverse cellular TGFβ1 and TGFβ3 gene expression in normal human and murine lung. Eur. Respir. J. 9, 2501-2507 (1996).
91. Yehualaeshet, T. et al. Activation of rat alveolar macrophage-derived latent transforming growth factor-β1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36. Am. J. Pathol. 155, 841-851 (1999).
92. Fernandez, S., Jose, P., Avdiushko, M. G., Kaplan, A. M. and Cohen, D. A. Inhibition of IL-10 receptor function in alveolar macrophages by Toll-like receptor agonists. J. Immunol. 172, 2613-2620 (2004).
93. Murray, P. J. Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response. Curr. Opin. Pharmacol. 6, 379-386 (2006).
94. Murray, P. J. The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription. Proc. Natl Acad. Sci. USA 102, 8686-8691 (2005).
95. Curtale, G. et al. Negative regulation of Toll-like receptor 4 signaling by IL-10-dependent microRNA-146b. Proc. Natl Acad. Sci. USA 110, 11499-11504 (2013).
96. Lim, S. et al. Differential expression of IL-10 receptor by epithelial cells and alveolar macrophages. Allergy 59, 505-514 (2004).
97. Chen, B. D., Mueller, M. and Chou, T. H. Role of granulocyte/macrophage colony-stimulating factor in the regulation of murine alveolar macrophage proliferation and differentiation. J. Immunol. 141, 139-144 (1988).
98. Higgins, D. M. et al. Relative levels of M-CSF and GM-CSF influence the specific generation of macrophage populations during infection with Mycobacterium tuberculosis. J. Immunol. 180, 4892-4900 (2008).
99. Trapnell, B. C. and Whitsett, J. A. GM-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense. Annu. Rev. Physiol. 64, 775-802 (2002).
100. Trapnell, B. C., Carey, B. C., Uchida, K. and Suzuki, T. Pulmonary alveolar proteinosis, a primary immunodeficiency of impaired GM-CSF stimulation of macrophages. Curr. Opin. Immunol. 21, 514-521 (2009).
101. Gautier, E. L. et al. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nature Immunol. 13, 1118-1128 (2012).
102. Malur, A. et al. Restoration of PPARγ reverses lipid accumulation in alveolar macrophages of GM-CSF knockout mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 300, L73-L80 (2011).
103. Gautier, E. L. et al. Systemic analysis of PPARγ in mouse macrophage populations reveals marked diversity in expression with critical roles in resolution of inflammation and airway immunity. J. Immunol. 189, 2614-2624 (2012).
104. Krysko, D. V., D'Herde, K. and Vandenabeele, P. Clearance of apoptotic and necrotic cells and its immunological consequences. Apoptosis 11, 1709-1726 (2006).
105. Lemke, G. and Rothlin, C. V. Immunobiology of the TAM receptors. Nature Rev. Immunol. 8, 327-336 (2008).
106. Klesney-Tait, J., Turnbull, I. R. and Colonna, M. The TREM receptor family and signal integration. Nature Immunol. 7, 1266-1273 (2006).
107. Powers, K. A. et al. Oxidative stress generated by hemorrhagic shock recruits Toll-like receptor 4 to the plasma membrane in macrophages. J. Exp. Med. 203, 1951-1961 (2006).
108. Maris, N. A. et al. Toll-like receptor mRNA levels in alveolar macrophages after inhalation of endotoxin. Eur. Respir. J. 28, 622-626 (2006).
109. Oshikawa, K. and Sugiyama, Y. Regulation of toll-like receptor 2 and 4 gene expression in murine alveolar macrophages. Exp. Lung Res. 29, 401-412 (2003).
110. Bilyk, N. and Holt, P. G. Cytokine modulation of the immunosuppressive phenotype of pulmonary alveolar macrophage populations. Immunology 86, 231-237 (1995).
111. Lohmann-Matthes, M. L., Steinmuller, C. and Franke-Ullmann, G. Pulmonary macrophages. Eur. Respir. J. 7, 1678-1689 (1994).
112. Steinmuller, C., Franke-Ullmann, G., Lohmann- Matthes, M. L. and Emmendorffer, A. Local activation of nonspecific defense against a respiratory model infection by application of interferon-γ: comparison between rat alveolar and interstitial lung macrophages. Am. J. Respir. Cell. Mol. Biol. 22, 481-490 (2000).
113. Naessens, T. et al. Innate imprinting of murine resident alveolar macrophages by allergic bronchial inflammation causes a switch from hypoinflammatory to hyperinflammatory reactivity. Am. J. Pathol. 181, 174-184 (2012).
114. Hogner, K. et al. Macrophage-expressed IFNβ contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia. PLoS. Pathog. 9, e1003188 (2013).
115. Herold, S. et al. Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand. J. Exp. Med. 205, 3065-3077 (2008).
116. Bem, R. A. et al. Potential role of soluble TRAIL in epithelial injury in children with severe RSV infection. Am. J. Respir. Cell. Mol. Biol. 42, 697-705 (2010).
117. Kim, H. M. et al. Alveolar macrophages are indispensable for controlling influenza viruses in lungs of pigs. J. Virol. 82, 4265-4274 (2008).
118. Tate, M. D., Pickett, D. L., van, R. N., Brooks, A. G. and Reading, P. C. Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice. J. Virol. 84, 7569-7580 (2010).
119. Tumpey, T. M. et al. Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J. Virol. 79, 14933-14944 (2005).
120. Maelfait, J. et al. A20 (Tnfaip3) deficiency in myeloid cells protects against influenza A virus infection. PLoS. Pathog. 8, e1002570 (2012).
121. Alber, A., Howie, S. E., Wallace, W. A. and Hirani, N. The role of macrophages in healing the wounded lung. Int. J. Exp. Pathol. 93, 243-251 (2012).
122. He, C., Ryan, A. J., Murthy, S. and Carter, A. B. Accelerated development of pulmonary fibrosis via Cu, Zn-superoxide dismutase-induced alternative activation of macrophages. J. Biol. Chem. 288, 20745-20757 (2013).
123. Gordon, S. and Martinez, F. O. Alternative activation of macrophages: mechanism and functions. Immunity. 32, 593-604 (2010).
124. Rouhani, F. N. et al. Alveolar macrophage dysregulation in Hermansky-Pudlak syndrome type 1. Am. J. Respir. Crit. Care Med. 180, 1114-1121 (2009).
125. Prieto, J. et al. Increased interleukin-13 mRNA expression in bronchoalveolar lavage cells of atopic patients with mild asthma after repeated low-dose allergen provocations. Respir. Med. 94, 806-814 (2000).
126. Magnan, A., van, P. D., Bongrand, P. and Vervloet, D. Alveolar macrophage interleukin (IL)-10 and IL-12 production in atopic asthma. Allergy 53, 1092-1095 (1998).
127. Gibbons, M. A. et al. Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. Am. J. Respir. Crit. Care Med. 184, 569-581 (2011).
128. Dhariwal, K. R., Shirvan, M. and Levine, M. Ascorbic acid regeneration in chromaffin granules. In situ kinetics. J. Biol. Chem. 266, 5384-5387 (1991).
129. Sun, K. and Metzger, D. W. Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nature Med. 14, 558-564 (2008).
130. Didierlaurent, A. et al. Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J. Exp. Med. 205, 323-329 (2008).
131. van der Sluijs, K. F. et al. IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J. Immunol. 172, 7603-7609 (2004).
132. Tokairin, Y. et al. Enhanced immediate inflammatory response to Streptococcus pneumoniae in the lungs of mice with pulmonary emphysema. Respirology. 13, 324-332 (2008).
133. Droemann, D. et al. Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients. Respir. Res. 6, 68 (2005).
134. Prescott, S. L. Effects of early cigarette smoke exposure on early immune development and respiratory disease. Paediatr. Respir. Rev. 9, 3-9 (2008).
135. Wang, J., Barke, R. A., Charboneau, R., Schwendener, R. and Roy, S. Morphine induces defects in early response of alveolar macrophages to Streptococcus pneumoniae by modulating TLR9- NF-κB signaling. J. Immunol. 180, 3594-3600 (2008).
136. Lievense, L. A., Bezemer, K., Aerts, J. G. and Hegmans, J. P. Tumor-associated macrophages in thoracic malignancies. Lung Cancer 80, 256-262 (2013).
137. Iverson, A. R. et al. Influenza virus primes mice for pneumonia from Staphylococcus aureus. J. Infect. Dis. 203, 880-888 (2011).
138. McCullers, J. A. et al. Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets. J. Infect. Dis. 202, 1287-1295 (2010).
139. Habibzay, M., Weiss, G. and Hussell, T. Bacterial superinfection following lung inflammatory disorders. Future. Microbiol. 8, 247-256 (2013).
140. Decramer, M., Janssens, W. and Miravitlles, M. Chronic obstructive pulmonary disease. Lancet 379, 1341-1351 (2012).
141. Jackson, D. J., Sykes, A., Mallia, P. and Johnston, S. L. Asthma exacerbations: origin, effect, and prevention. J. Allergy Clin. Immunol. 128, 1165-1174 (2011).
142. Walzl, G., Tafuro, S., Moss, P., Openshaw, P. J. and Hussell, T. Influenza virus lung infection protects from respiratory syncytial virus-induced immunopathology. J. Exp. Med. 192, 1317-1326 (2000).
143. Kasahara, K. et al. Intranasal priming of newborn mice with microbial extracts increases opsonic factors and mature CD11c+ cells in the airway. Am. J. Physiol. Lung Cell. Mol. Physiol. 303, L834-L843 (2012).
144. Kurkjian, C. et al. Alveolar macrophages in neonatal mice are inherently unresponsive to Pneumocystis murina infection. Infect. Immun. 80, 2835-2846 (2012).
145. von Garnier, C. et al. Allergic airways disease develops after an increase in allergen capture and processing in the airway mucosa. J. Immunol. 179, 5748-5759 (2007).
146. Wang, J. Y. and Reid, K. B. The immunoregulatory roles of lung surfactant collectins SP-A, and SP-D, in allergen-induced airway inflammation. Immunobiology 212, 417-425 (2007).
147. Poulter, L. W., Janossy, G., Power, C., Sreenan, S. and Burke, C. Immunological/physiological relationships in asthma: potential regulation by lung macrophages. Immunol. Today 15, 258-261 (1994).
148. Wissinger, E., Goulding, J. and Hussell, T. Immune homeostasis in the respiratory tract and its impact on heterologous infection. Semin. Immunol. 21, 147-155 (2009).
149. Brown, S. D. et al. Airway TGFβ1 and oxidant stress in children with severe asthma: association with airflow limitation. J. Allergy Clin. Immunol. 129, 388-396. e1-e8 (2012).
150. Fitzpatrick, A. M., Teague, W. G., Burwell, L., Brown, M. S. and Brown, L. A. Glutathione oxidation is associated with airway macrophage functional impairment in children with severe asthma. Pediatr. Res. 69, 154-159 (2011).
151. Fitzpatrick, A. M., Higgins, M., Holguin, F., Brown, L. A. and Teague, W. G. The molecular phenotype of severe asthma in children. J. Allergy Clin. Immunol. 125, 851-857 (2010).
152. Fitzpatrick, A. M., Holguin, F., Teague, W. G. and Brown, L. A. Alveolar macrophage phagocytosis is impaired in children with poorly controlled asthma. J. Allergy Clin. Immunol. 121, 1372-1378.e3 (2008).
153. Lemanske, R. F. Jr. Inflammation in childhood asthma and other wheezing disorders. Pediatrics 109, 368-372 (2002).
154. Pappas, K., Papaioannou, A. I., Kostikas, K. and Tzanakis, N. The role of macrophages in obstructive airways disease: Chronic obstructive pulmonary disease and asthma. Cytokine 64, 613-625 (2013).
155. Burastero, S. E. et al. Increased expression of the CD80 accessory molecule by alveolar macrophages in asthmatic subjects and its functional involvement in allergen presentation to autologous TH2 lymphocytes. J. Allergy Clin. Immunol. 103, 1136-1142 (1999).
156. Nicod, L. P. and Isler, P. Alveolar macrophages in sarcoidosis coexpress high levels of CD86 (B7.2), CD40, and CD30L. Am. J. Respir. Cell. Mol. Biol. 17, 91-96 (1997).
157. Dobbs, L. G. and Johnson, M. D. Alveolar epithelial transport in the adult lung. Respir. Physiol. Neurobiol. 159, 283-300 (2007).
158. Tam, A., Wadsworth, S., Dorscheid, D., Man, S. F. and Sin, D. D. The airway epithelium: more than just a structural barrier. Ther. Adv. Respir. Dis. 5, 255-273 (2011).
159. Wang, Y. et al. A critical role of activin A in maturation of mouse peritoneal macrophages in vitro and in vivo. Cell Mol. Immunol. 6, 387-392 (2009).
160. Austyn, J. M. and Gordon, S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol. 11, 805-815 (1981).
161. Liu, G. et al. Phenotypic and functional switch of macrophages induced by regulatory CD4+CD25+ T cells in mice. Immunol. Cell Biol. 89, 130-142 (2011).
162. Feng, Y. H. and Mao, H. Expression and preliminary functional analysis of Siglec-F on mouse macrophages. J. Zhejiang Univ. Sci. B 13, 386-394 (2012).